Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Cynosure, Inc. (CYNO)

Page 1 of 2

Is it smart to be bullish on Cynosure, Inc. (NASDAQ:CYNO)?

In the eyes of many of your fellow readers, hedge funds are viewed as useless, outdated financial vehicles of a period lost to current times. Although there are over 8,000 hedge funds with their doors open in present day, Insider Monkey focuses on the elite of this group, close to 525 funds. It is assumed that this group controls the lion’s share of all hedge funds’ total assets, and by paying attention to their highest performing stock picks, we’ve identified a number of investment strategies that have historically beaten the broader indices. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points per annum for a decade in our back tests, and since we‘ve began to sharing our picks with our subscribers at the end of August 2012, we have trumped the S&P 500 index by 33 percentage points in 11 months (explore the details and some picks here).

Just as key, optimistic insider trading sentiment is another way to analyze the stock market universe. Obviously, there are a number of stimuli for an upper level exec to get rid of shares of his or her company, but only one, very simple reason why they would buy. Various academic studies have demonstrated the impressive potential of this tactic if “monkeys” know where to look (learn more here).

What’s more, it’s important to study the recent info for Cynosure, Inc. (NASDAQ:CYNO).

How have hedgies been trading Cynosure, Inc. (NASDAQ:CYNO)?

At Q2’s end, a total of 19 of the hedge funds we track were bullish in this stock, a change of 19% from the previous quarter. With the smart money’s capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their holdings substantially.

Cynosure, Inc. (NASDAQ:CYNO)When using filings from the hedgies we track, Neal C. Bradsher’s Broadwood Capital had the largest position in Cynosure, Inc. (NASDAQ:CYNO), worth close to $21.2 million, comprising 4.8% of its total 13F portfolio. Coming in second is Healthcor Management LP, managed by Arthur B Cohen and Joseph Healey, which held a $15.6 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Remaining peers that are bullish include Steven Cohen’s SAC Capital Advisors, Israel Englander’s Millennium Management and Constantinos J. Christofilis’s Archon Capital Management.

Now, certain money managers were leading the bulls’ herd. Broadwood Capital, managed by Neal C. Bradsher, assembled the most valuable position in Cynosure, Inc. (NASDAQ:CYNO). Broadwood Capital had 21.2 million invested in the company at the end of the quarter. Arthur B Cohen and Joseph Healey’s Healthcor Management LP also made a $15.6 million investment in the stock during the quarter. The following funds were also among the new CYNO investors: Steven Cohen’s SAC Capital Advisors, Israel Englander’s Millennium Management, and Constantinos J. Christofilis’s Archon Capital Management.

What have insiders been doing with Cynosure, Inc. (NASDAQ:CYNO)?

Legal insider trading, particularly when it’s bullish, is best served when the company we’re looking at has seen transactions within the past half-year. Over the latest six-month time frame, Cynosure, Inc. (NASDAQ:CYNO) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Cynosure, Inc. (NASDAQ:CYNO). These stocks are Cardiovascular Systems Inc (NASDAQ:CSII), Natus Medical Inc (NASDAQ:BABY), Invacare Corporation (NYSE:IVC), Symmetry Medical Inc. (NYSE:SMA), and GenMark Diagnostics, Inc (NASDAQ:GNMK). All of these stocks are in the medical appliances & equipment industry and their market caps are closest to CYNO’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!